Analysis and validation of necroptosis-related diagnostic biomarkers associated with immune infiltration in bronchopulmonary dysplasia

Analysis and validation of necroptosis-related diagnostic biomarkers associated with immune infiltration in bronchopulmonary dysplasia

BackgroundBronchopulmonary dysplasia (BPD) is the most common serious complication in very preterm infants. This study aims to identify necroptosis-related genes (NRGs) and analyze the relationship between necroptosis-related diagnostic markers and immune infiltration in BPD.MethodsWe obtained the d...

Full description

Saved in:

Bibliographic Details
Main Authors:	Haixia Tu, Changjiang Fang, Ping Gan, Yunyun Gu, Nana Peng, Honghua Jiang, Weiwei Hou, Guihua Shu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-07-01
Series:	Frontiers in Pediatrics
Subjects:	bronchopulmonary dysplasia necroptosis diagnostic biomarkers immune infiltration preterm infants
Online Access:	https://www.frontiersin.org/articles/10.3389/fped.2025.1578628/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Decreased neutrophil levels in bronchopulmonary dysplasia infants
by: Xingchao Li, et al.
Published: (2020-12-01)

Proteomic analysis of premature umbilical cord blood and its relationship with bronchopulmonary dysplasia
by: Jia Chen, et al.
Published: (2025-03-01)

Evaluation of melatonin efficacy in prevention of bronchopulmonary dysplasia in preterm newborn infants
by: Manizheh Mostafa Gharehbaghi, et al.
Published: (2022-02-01)

Association between gastroesophageal reflux and bronchopulmonary dysplasia in preterm infants: a systematic review and meta-analysis
by: XinYi Yu, et al.
Published: (2025-06-01)

Can the Oxygen Saturation Index Predict Severe Bronchopulmonary Dysplasia?
by: Hulya Ozdemir, et al.
Published: (2025-04-01)

Comparative analysis of three bronchopulmonary dysplasia diagnostic criteria in predicting longterm neurodevelopmental outcomes in preterm infants
by: Rui Li, et al.
Published: (2025-08-01)

Development and external validation of a machine learning model to predict bronchopulmonary dysplasia using dynamic factors
by: Ho Jung Choi, et al.
Published: (2025-04-01)

Clinical analysis and predictive value of early serum lipid levels in very premature and extremely preterm infants with bronchopulmonary dysplasia: a 4 years retrospective study
by: Zhenyu Xiong, et al.
Published: (2025-02-01)

Increased bronchopulmonary dysplasia along with decreased mortality in extremely preterm infants
by: Ga Won Jeon, et al.
Published: (2025-03-01)

Intratracheal administration of budesonide with surfactant in very low birth weight infants to prevent bronchopulmonary dysplasia
by: Minji Heo, et al.
Published: (2020-08-01)

Early low-dose hydrocortisone is associated with a reduced risk of bronchopulmonary dysplasia in infants born at less than 26 weeks' gestational age
by: Fang Yao, et al.
Published: (2025-04-01)

Reinitiating lung development: a novel approach in the management of bronchopulmonary dysplasia
by: Xuewei Cui, et al.
Published: (2024-10-01)

Platelet-Related Indicators: Potential Role in Early Prediction of Bronchopulmonary Dysplasia
by: Xixi Zhang, et al.
Published: (2024-09-01)

Third-day weight changes and bronchopulmonary dysplasia risk in preterm infants: a cohort study
by: Wenqian Chen, et al.
Published: (2025-05-01)

Efficacy of vibroacoustic therapy in treatment of pneumonia in children with bronchopulmonary dysplasia
by: Madina Syzdykova, et al.
Published: (2023-09-01)

Criteria for the duration of anti-inflammatory therapy in children with bronchopulmonary dysplasia
by: Т. І. Stepanenko, et al.
Published: (2019-04-01)

Metabolic acidosis as a risk factor for bronchopulmonary dysplasia in preterm infants born between 23 + 0 and 31 + 6 weeks of gestation: a retrospective case-control study
by: T. W. Shin, et al.
Published: (2025-06-01)

Intestinal microbiota changes in early life of very preterm infants with bronchopulmonary dysplasia: a nested case–control study
by: Tao Ning, et al.
Published: (2025-07-01)

Inhaled nitric oxide as an independent intervention to lower the risk of bronchopulmonary dysplasia in preterm infants (< 33 weeks) with pulmonary hypertension within the initial 3 days of life
by: Tasnim Azad, et al.
Published: (2025-07-01)

Advancements in biomarkers and machine learning for predicting of bronchopulmonary dysplasia and neonatal respiratory distress syndrome in preterm infants
by: Hanieh Talebi, et al.
Published: (2025-04-01)

The association between the microbes in the tracheobronchial aspirate fluid and bronchopulmonary dysplasia in preterm infants
by: Xiao-yan Gao, et al.
Published: (2020-06-01)

Association of TNF-α genetic variants with neonatal bronchopulmonary dysplasia: consolidated results
by: Seyedeh Elham Shams, et al.
Published: (2024-12-01)

Outcomes of extremely preterm infants with bronchopulmonary dysplasia: a retrospective cohort study
by: Ashraf Gad, et al.
Published: (2025-07-01)

Meta-analysis of budesonide and surfactant combination for the prevention of bronchopulmonary dysplasia in preterm neonates based on gestational age
by: Sedigheh Ekraminasab, et al.
Published: (2025-04-01)

Correlates of Elevated Interleukin-6 and 8-Hydroxy-2′-Deoxyguanosine Levels in Tracheal Aspirates from Very Low Birth Weight Infants Who Develop Bronchopulmonary Dysplasia
by: Chien-Chou Hsiao, et al.
Published: (2017-02-01)

Enhanced vs. standard low dose dexamethasone treatment on respiratory outcomes of preterm infants with bronchopulmonary dysplasia
by: Sezgin Gunes, et al.
Published: (2025-08-01)

Delayed Dexamethasone Therapy and Neurodevelopmental Outcomes in Preterm Infants with Bronchopulmonary Dysplasia
by: Gina Lim, et al.
Published: (2015-08-01)

Bronchopulmonary Dysplasia: a Modern View on Course and Outcomes
by: K. A. Kazakova
Published: (2016-11-01)

The significance of IL-1β +3953C>T, IL-6 -174G>C and -596G>A, TNF-α -308G>A gene polymorphisms and 86 bp variable number tandem repeat polymorphism of IL-1RN in bronchopulmonary dysplasia in infants born before 32 weeks of gestation
by: Dawid Szpecht, et al.
Published: (2017-06-01)

Evaluation of mediators of fibrosis and angiogenesis in the blood serum of premature infants with bronchopulmonary dysplasia
by: E. L. Semikina, et al.
Published: (2023-06-01)

Single, double, and triple-hit strategies to establish a long-term premature rabbit model of bronchopulmonary dysplasia
by: Chiara Catozzi, et al.
Published: (2025-01-01)

Genetic Determination of Bronchopulmonary Dysplasia Formation: Pros and Cons
by: V. K. Pozharishchenskaya, et al.
Published: (2017-05-01)

Predictors of bronchopulmonary dysplasia occurrence and severity in extremely preterm infants
by: Xuejing Liu, et al.
Published: (2025-08-01)

Correlation analysis between patent ductus arteriosus and bronchopulmonary dysplasia in premature infants
by: Hao Luo, et al.
Published: (2025-08-01)

Shifting Paradigms in Bronchopulmonary Dysplasia: From Treatment to Etiology/Pathophysiology-Based Classification
by: Fumihiko Namba, et al.
Published: (2025-04-01)

A Practical, Evidence-Based Approach to Postneonatal Management of Children with Bronchopulmonary Dysplasia
by: Caroline Poulter, et al.
Published: (2019-07-01)

The Most Important Risk Factors and Associated Morbidities of Bronchopulmonary Dysplasia, the Never Ending Problem of Preterms
by: Ayşen Bayrak, et al.
Published: (2025-08-01)

Assessment of Safety, Immunogenicity and Preventive Efficacy of Prevenar-13 in Children with Bronchopulmonary Dysplasia
by: E. S. Zubova, et al.
Published: (2018-04-01)

Elevated visfatin levels illuminate the inflammatory path in bronchopulmonary dysplasia
by: Berna Hoti, et al.
Published: (2024-12-01)

Postnatal corticosteroids to prevent bronchopulmonary dysplasia: balancing benefits and risks. A narrative review
by: Gustavo Rocha
Published: (2025-04-01)